🇺🇸 FDA
Pipeline program

MC-1-50

PB12

Phase 1 mab active

Quick answer

MC-1-50 for Acute Lymphoblastic Leukemia, in Relapse is a Phase 1 program (mab) at PRECISION BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).

Program details

Company
PRECISION BIOSCIENCES INC
Indication
Acute Lymphoblastic Leukemia, in Relapse
Phase
Phase 1
Modality
mab
Status
active

Clinical trials